All In Biotech

Drug Trial Radar · NCT00930618

Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies

NOCETER, a Multicenter Double Blind Placebo-controlled Randomized Trial: Reduction of CEsareans in Post TERm Pregnancies: Impact of Outpatient Cervical Ripening With NO Donors

Last checked: Nov 20, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,409 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,409

Actual

Start

Jun 2009

Primary completion

Dec 2013

Study completion Apr 2014

Sponsor

Lead sponsor
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
URC-CIC Paris Descartes Necker Cochin
First posted
Jun 30, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is to determine whether cervical ripening with isosorbide mononitrate reduce caesarean section in women with post term pregnancies.

Conditions

  • Prolonged Pregnancy
  • Nulliparity

Interventions

  • IMNDrug

    Administration of 2 x 20 mg of isosorbide mononitrate at each administration with a maximum of three administrations

  • PlaceboDrug

    Administration of 2 X 20 mg of placebo of IMN at each administration with a maximum of three administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of cesarean sectionsTime frame: 10 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Robert Debré Hospital

    Paris, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.